Cargando…

Management of patients with liver diseases on the waiting list for transplantation: a major impact to the success of liver transplantation

BACKGROUND: The results of liver transplantation are excellent, with survival rates of over 90 and 80% at 1 and 5 years, respectively. The success of liver transplantation has led to an increase in the indications for liver transplantation. Generally, priorities are given to cirrhotic patients with...

Descripción completa

Detalles Bibliográficos
Autores principales: Samuel, Didier, Coilly, Audrey
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6069832/
https://www.ncbi.nlm.nih.gov/pubmed/30064414
http://dx.doi.org/10.1186/s12916-018-1110-y
_version_ 1783343579700133888
author Samuel, Didier
Coilly, Audrey
author_facet Samuel, Didier
Coilly, Audrey
author_sort Samuel, Didier
collection PubMed
description BACKGROUND: The results of liver transplantation are excellent, with survival rates of over 90 and 80% at 1 and 5 years, respectively. The success of liver transplantation has led to an increase in the indications for liver transplantation. Generally, priorities are given to cirrhotic patients with a high Model for End-Stage Liver Disease (MELD) score on the principle of the sickest first and to patients with hepatocellular carcinoma (HCC) on the principle of priority points according to the size and number of nodules of HCC. These criteria can lead to a ‘competition’ on the waiting list between the above patients and those who are cirrhotic and have an intermediate MELD score or with life-threatening liver diseases not well described by the MELD score. For this latter group of patients, ‘MELD exception’ points can be arbitrarily given. DISCUSSION: The management of patients on the waiting list is of prime importance to avoid death and drop out from the waiting list as well as to improve post-transplant survival rates. For the more severe cases who may swiftly access liver transplantation, it is essential to rapidly determine whether liver transplantation is indeed indicated, and to organise a fast workup ahead of this. It is also essential to identify the ideal timing for liver transplantation in order to minimise mortality rates. For patients with HCC, a bridge therapy is frequently required to avoid progression of HCC and to maintain patients within the criteria of liver transplantation as well as to reduce the risk of post-transplant recurrence of HCC. For patients with cirrhosis and intermediate MELD score, waiting time can exceed 1 year; therefore, regular follow-up and management are essential to maintain the patient alive on the waiting list and to achieve a good survival after liver transplantation. CONCLUSION: There is a diversity of patients on the waiting list for transplantation and equity should be preserved between those with cirrhosis of high and intermediate severity and those with HCC. The management of patients on the waiting list is an essential component of the success of liver transplantation.
format Online
Article
Text
id pubmed-6069832
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-60698322018-08-06 Management of patients with liver diseases on the waiting list for transplantation: a major impact to the success of liver transplantation Samuel, Didier Coilly, Audrey BMC Med Opinion BACKGROUND: The results of liver transplantation are excellent, with survival rates of over 90 and 80% at 1 and 5 years, respectively. The success of liver transplantation has led to an increase in the indications for liver transplantation. Generally, priorities are given to cirrhotic patients with a high Model for End-Stage Liver Disease (MELD) score on the principle of the sickest first and to patients with hepatocellular carcinoma (HCC) on the principle of priority points according to the size and number of nodules of HCC. These criteria can lead to a ‘competition’ on the waiting list between the above patients and those who are cirrhotic and have an intermediate MELD score or with life-threatening liver diseases not well described by the MELD score. For this latter group of patients, ‘MELD exception’ points can be arbitrarily given. DISCUSSION: The management of patients on the waiting list is of prime importance to avoid death and drop out from the waiting list as well as to improve post-transplant survival rates. For the more severe cases who may swiftly access liver transplantation, it is essential to rapidly determine whether liver transplantation is indeed indicated, and to organise a fast workup ahead of this. It is also essential to identify the ideal timing for liver transplantation in order to minimise mortality rates. For patients with HCC, a bridge therapy is frequently required to avoid progression of HCC and to maintain patients within the criteria of liver transplantation as well as to reduce the risk of post-transplant recurrence of HCC. For patients with cirrhosis and intermediate MELD score, waiting time can exceed 1 year; therefore, regular follow-up and management are essential to maintain the patient alive on the waiting list and to achieve a good survival after liver transplantation. CONCLUSION: There is a diversity of patients on the waiting list for transplantation and equity should be preserved between those with cirrhosis of high and intermediate severity and those with HCC. The management of patients on the waiting list is an essential component of the success of liver transplantation. BioMed Central 2018-08-01 /pmc/articles/PMC6069832/ /pubmed/30064414 http://dx.doi.org/10.1186/s12916-018-1110-y Text en © The Author(s). 2018 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Opinion
Samuel, Didier
Coilly, Audrey
Management of patients with liver diseases on the waiting list for transplantation: a major impact to the success of liver transplantation
title Management of patients with liver diseases on the waiting list for transplantation: a major impact to the success of liver transplantation
title_full Management of patients with liver diseases on the waiting list for transplantation: a major impact to the success of liver transplantation
title_fullStr Management of patients with liver diseases on the waiting list for transplantation: a major impact to the success of liver transplantation
title_full_unstemmed Management of patients with liver diseases on the waiting list for transplantation: a major impact to the success of liver transplantation
title_short Management of patients with liver diseases on the waiting list for transplantation: a major impact to the success of liver transplantation
title_sort management of patients with liver diseases on the waiting list for transplantation: a major impact to the success of liver transplantation
topic Opinion
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6069832/
https://www.ncbi.nlm.nih.gov/pubmed/30064414
http://dx.doi.org/10.1186/s12916-018-1110-y
work_keys_str_mv AT samueldidier managementofpatientswithliverdiseasesonthewaitinglistfortransplantationamajorimpacttothesuccessoflivertransplantation
AT coillyaudrey managementofpatientswithliverdiseasesonthewaitinglistfortransplantationamajorimpacttothesuccessoflivertransplantation